BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6088248)

  • 1. Combined modality treatment of short duration in small cell lung cancer.
    Bakker W; Nijhuis-Heddes JM; van Oosterom AT; Noordijk EM; Hermans J; Dijkman JH
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1033-7. PubMed ID: 6088248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
    J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemo-radiotherapy and maintenance alternating chemotherapy for small cell lung cancer.
    Tummarello D; Guidi F; Torresi U; Isidori P; Rossi A; Dazzi C; Cellerino R
    Acta Oncol; 1990; 29(4):417-20. PubMed ID: 2167701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
    Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full chemotherapy in elderly patients with small cell bronchial carcinoma.
    Nõu E
    Acta Oncol; 1996; 35(4):399-406. PubMed ID: 8695151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens.
    Nõu E; Brodin O; Bergh J
    Cancer; 1988 Sep; 62(6):1079-90. PubMed ID: 2457422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.
    Feld R; Evans WK; DeBoer G; Quirt IC; Shepherd FA; Yeoh JL; Pringle JF; Payne DG; Herman JG; Chamberlain D
    J Clin Oncol; 1984 Apr; 2(4):294-304. PubMed ID: 6323640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer.
    Park YJ; Koh EH; Kim J; Roh JK; Chang J; Ahn CM; Sohn HY; Kim SK; Lee WY; Kim K
    Yonsei Med J; 1989; 30(1):30-7. PubMed ID: 2545051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
    Kies MS; Mira JG; Crowley JJ; Chen TT; Pazdur R; Grozea PN; Rivkin SE; Coltman CA; Ward JH; Livingston RB
    J Clin Oncol; 1987 Apr; 5(4):592-600. PubMed ID: 3031226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A combination chemotherapy consisting of vincristine, etoposide and cyclophosphamide (VEC) for small cell carcinoma of the lung].
    Adachi K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Nakata H; Tada A; Aiba K
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1617-22. PubMed ID: 6089668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress and obstacles in chemotherapy and combined modality treatment of small cell lung cancer].
    Ohnoshi T; Ueoka H; Numata T; Kawahara S; Nishii K; Yonei T; Mima Y; Horiguchi T; Kiura K; Moritaka T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):190-6. PubMed ID: 2162437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
    Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy induction, consolidation radiotherapy and maintenance alternating chemotherapy in small cell carcinoma of the lung.
    Warner-Efrati E; Sulkes A; Weshler Z; Peretz T; Ben-Yosef R; Catane R; Biran S
    Isr J Med Sci; 1988; 24(9-10):593-8. PubMed ID: 2849598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sequential induction chemotherapy and radiation treatment of inoperable small cell bronchial cancer. Results of a prospective randomized study].
    Schütte J; Niederle N; Eberhardt W; Seeber S; Alberti W; Budach V; Hirche H; Schmidt CG
    Klin Wochenschr; 1989 Dec; 67(23):1182-93. PubMed ID: 2558254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.
    Souhami RL; Rudd R; Ruiz de Elvira MC; James L; Gower N; Harper PG; Tobias JS; Partridge MR; Davison AG; Trask C
    J Clin Oncol; 1994 Sep; 12(9):1806-13. PubMed ID: 8083704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CMC chemotherapy regimen combined with surgery of small cell lung cancer (SCLC)].
    Liao ML; Xu CW; Huang OL; Zhou YZ; Cao YF; Chen YR
    Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):453-5. PubMed ID: 3034537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung.
    Beith JM; Clarke SJ; Woods RL; Bell DR; Levi JA
    Eur J Cancer; 1996 Mar; 32A(3):438-43. PubMed ID: 8814688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.